These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 25380242)

  • 1. A comprehensive genomic approach for neuromuscular diseases gives a high diagnostic yield.
    Ankala A; da Silva C; Gualandi F; Ferlini A; Bean LJ; Collins C; Tanner AK; Hegde MR
    Ann Neurol; 2015 Feb; 77(2):206-14. PubMed ID: 25380242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next generation sequencing panel as an effective approach to genetic testing in patients with a highly variable phenotype of neuromuscular disorders.
    Radziwonik-Fraczyk W; Elert-Dobkowska E; Karpinski M; Pilch J; Ziora-Jakutowicz K; Kubalska J; Szczesniak D; Stepniak I; Zaremba J; Sulek A
    Neurogenetics; 2024 Jul; 25(3):233-247. PubMed ID: 38758368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotype-guided diagnostic reassessment after exome sequencing in neuromuscular disorders: experiences with a two-step approach.
    Krenn M; Tomschik M; Rath J; Cetin H; Grisold A; Zulehner G; Milenkovic I; Stogmann E; Zimprich A; Strom TM; Meitinger T; Wagner M; Zimprich F
    Eur J Neurol; 2020 Jan; 27(1):51-61. PubMed ID: 31407473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical validation of targeted next-generation sequencing for inherited disorders.
    Yohe S; Hauge A; Bunjer K; Kemmer T; Bower M; Schomaker M; Onsongo G; Wilson J; Erdmann J; Zhou Y; Deshpande A; Spears MD; Beckman K; Silverstein KA; Thyagarajan B
    Arch Pathol Lab Med; 2015 Feb; 139(2):204-10. PubMed ID: 25611102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Panel-Based Exome Sequencing for Neuromuscular Disorders as a Diagnostic Service.
    Westra D; Schouten MI; Stunnenberg BC; Kusters B; Saris CGJ; Erasmus CE; van Engelen BG; Bulk S; Verschuuren-Bemelmans CC; Gerkes EH; de Geus C; van der Zwaag PA; Chan S; Chung B; Barge-Schaapveld DQCM; Kriek M; Sznajer Y; van Spaendonck-Zwarts K; van der Kooi AJ; Krause A; Schönewolf-Greulich B; de Die-Smulders C; Sallevelt SCEH; Krapels IPC; Rasmussen M; Maystadt I; Kievit AJA; Witting N; Pennings M; Meijer R; Gillissen C; Kamsteeg EJ; Voermans NC
    J Neuromuscul Dis; 2019; 6(2):241-258. PubMed ID: 31127727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rapid evolution of molecular genetic diagnostics in neuromuscular diseases.
    Volk AE; Kubisch C
    Curr Opin Neurol; 2017 Oct; 30(5):523-528. PubMed ID: 28665809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of comprehensive targeted multigene panel sequencing for neuromuscular disorders in Korean patients.
    Park J; Oh HM; Park HJ; Cho AR; Lee DW; Jang JH; Jang DH
    Mol Genet Genomic Med; 2019 Oct; 7(10):e00947. PubMed ID: 31475473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetics of neuromuscular disorders.
    Laing NG
    Crit Rev Clin Lab Sci; 2012; 49(2):33-48. PubMed ID: 22468856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of targeted multi-gene panel testing for the diagnosis of inherited peripheral neuropathy provides a high diagnostic yield with unexpected phenotype-genotype variability.
    Antoniadi T; Buxton C; Dennis G; Forrester N; Smith D; Lunt P; Burton-Jones S
    BMC Med Genet; 2015 Sep; 16():84. PubMed ID: 26392352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Target resequencing of neuromuscular disease-related genes using next-generation sequencing for patients with undiagnosed early-onset neuromuscular disorders.
    Kitamura Y; Kondo E; Urano M; Aoki R; Saito K
    J Hum Genet; 2016 Nov; 61(11):931-942. PubMed ID: 27357428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscular dystrophies and myopathies: the spectrum of mutated genes in the Czech Republic.
    Stehlíková K; Skálová D; Zídková J; Haberlová J; Voháňka S; Mazanec R; Mrázová L; Vondráček P; Ošlejšková H; Zámečník J; Honzík T; Zeman J; Magner M; Šišková D; Langová M; Gregor V; Godava M; Smolka V; Fajkusová L
    Clin Genet; 2017 Mar; 91(3):463-469. PubMed ID: 27447704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved diagnostic yield of neuromuscular disorders applying clinical exome sequencing in patients arising from a consanguineous population.
    Fattahi Z; Kalhor Z; Fadaee M; Vazehan R; Parsimehr E; Abolhassani A; Beheshtian M; Zamani G; Nafissi S; Nilipour Y; Akbari MR; Kahrizi K; Kariminejad A; Najmabadi H
    Clin Genet; 2017 Mar; 91(3):386-402. PubMed ID: 27234031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of whole-exome sequencing in Chinese pediatric-onset neuromuscular patients.
    Tsang MHY; Chiu ATG; Kwong BMH; Liang R; Yu MHC; Yeung KS; Ho WHL; Mak CCY; Leung GKC; Pei SLC; Fung JLF; Wong VCN; Muntoni F; Chung BHY; Chan SHS
    Mol Genet Genomic Med; 2020 May; 8(5):e1205. PubMed ID: 32154989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Extended Targeted Copy Number Variation Detection Array Including 187 Genes for the Diagnostics of Neuromuscular Disorders.
    Sagath L; Lehtokari VL; Välipakka S; Udd B; Wallgren-Pettersson C; Pelin K; Kiiski K
    J Neuromuscul Dis; 2018; 5(3):307-314. PubMed ID: 30040739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next-generation diagnostics: gene panel, exome, or whole genome?
    Sun Y; Ruivenkamp CA; Hoffer MJ; Vrijenhoek T; Kriek M; van Asperen CJ; den Dunnen JT; Santen GW
    Hum Mutat; 2015 Jun; 36(6):648-55. PubMed ID: 25772376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted Next-Generation Sequencing in a Large Cohort of Genetically Undiagnosed Patients with Neuromuscular Disorders in Spain.
    Gonzalez-Quereda L; Rodriguez MJ; Diaz-Manera J; Alonso-Perez J; Gallardo E; Nascimento A; Ortez C; Natera-de Benito D; Olive M; Gonzalez-Mera L; Munain AL; Zulaica M; Poza JJ; Jerico I; Torne L; Riera P; Milisenda J; Sanchez A; Garrabou G; Llano I; Madruga-Garrido M; Gallano P
    Genes (Basel); 2020 May; 11(5):. PubMed ID: 32403337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next generation sequencing and its application in the diagnostics of neuromuscular diseases.
    Zídková J; Haberlová J; Kramářová T; Fajkusová L
    Cesk Patol; 2021; 57(3):150-153. PubMed ID: 34551563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic testing offer for inherited neuromuscular diseases within the EURO-NMD reference network: A European survey study.
    Peterlin B; Gualandi F; Maver A; Servidei S; van der Maarel SM; Lamy F; Mejat A; Evangelista T; Ferlini A
    PLoS One; 2020; 15(9):e0239329. PubMed ID: 32946487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diversity of hereditary neuromuscular diseases: Experiences from molecular diagnosis.
    Hsueh HW; Weng WC; Fan PC; Chien YH; Yang FJ; Lee WT; Lin RJ; Hwu WL; Yang CC; Lee NC
    J Formos Med Assoc; 2022 Dec; 121(12):2574-2583. PubMed ID: 35821219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted gene panel use in 2249 neuromuscular patients: the Australasian referral center experience.
    Beecroft SJ; Yau KS; Allcock RJN; Mina K; Gooding R; Faiz F; Atkinson VJ; Wise C; Sivadorai P; Trajanoski D; Kresoje N; Ong R; Duff RM; Cabrera-Serrano M; Nowak KJ; Pachter N; Ravenscroft G; Lamont PJ; Davis MR; Laing NG
    Ann Clin Transl Neurol; 2020 Mar; 7(3):353-362. PubMed ID: 32153140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.